| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China C Huang, Y Wang, X Li, L Ren, J Zhao, Y Hu, L Zhang, G Fan, J Xu, X Gu, ... The lancet 395 (10223), 497-506, 2020 | 59885 | 2020 |
| RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study C Huang, L Huang, Y Wang, X Li, L Ren, X Gu, L Kang, L Guo, M Liu, ... The Lancet 397 (10270), 220-232, 2021 | 4743 | 2021 |
| Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV X Ou, Y Liu, X Lei, P Li, D Mi, L Ren, L Guo, R Guo, T Chen, J Hu, Z Xiang, ... Nature communications 11 (1), 1620, 2020 | 3240 | 2020 |
| Profiling early humoral response to diagnose novel coronavirus disease (COVID-19) L Guo, L Ren, S Yang, M Xiao, D Chang, F Yang, CS Dela Cruz, Y Wang, ... Clinical infectious diseases 71 (15), 778-785, 2020 | 2103 | 2020 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review … T Shi, DA McAllister, KL O'Brien, EAF Simoes, SA Madhi, BD Gessner, ... The Lancet 390 (10098), 946-958, 2017 | 2103 | 2017 |
| Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study LL Ren, YM Wang, ZQ Wu, ZC Xiang, L Guo, T Xu, YZ Jiang, Y Xiong, ... Chinese medical journal 133 (09), 1015-1024, 2020 | 1865 | 2020 |
| Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial L Li, W Zhang, Y Hu, X Tong, S Zheng, J Yang, Y Kong, L Ren, Q Wei, ... Jama 324 (5), 460-470, 2020 | 1546 | 2020 |
| Heightened innate immune responses in the respiratory tract of COVID-19 patients Z Zhou, L Ren, L Zhang, J Zhong, Y Xiao, Z Jia, L Guo, J Yang, C Wang, ... Cell host & microbe 27 (6), 883-890. e2, 2020 | 935 | 2020 |
| 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study L Huang, Q Yao, X Gu, Q Wang, L Ren, Y Wang, P Hu, L Guo, M Liu, J Xu, ... The lancet 398 (10302), 747-758, 2021 | 906 | 2021 |
| Activation and evasion of type I interferon responses by SARS-CoV-2 X Lei, X Dong, R Ma, W Wang, X Xiao, Z Tian, C Wang, Y Wang, L Li, ... Nature communications 11 (1), 3810, 2020 | 890 | 2020 |
| Genomic diversity of severe acute respiratory syndrome–coronavirus 2 in patients with coronavirus disease 2019 Z Shen, Y Xiao, L Kang, W Ma, L Shi, L Zhang, Z Zhou, J Yang, J Zhong, ... Clinical infectious diseases 71 (15), 713-720, 2020 | 631 | 2020 |
| Enterovirus 71 outbreak in the People's Republic of China in 2008 F Yang, L Ren, Z Xiong, J Li, Y Xiao, R Zhao, Y He, G Bu, S Zhou, J Wang, ... Journal of clinical microbiology 47 (7), 2351-2352, 2009 | 413 | 2009 |
| Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study L Huang, X Li, X Gu, H Zhang, LL Ren, L Guo, M Liu, Y Wang, D Cui, ... The Lancet Respiratory Medicine 10 (9), 863-876, 2022 | 379 | 2022 |
| Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26 Q Wang, J Qi, Y Yuan, Y Xuan, P Han, Y Wan, W Ji, Y Li, Y Wu, J Wang, ... Cell host & microbe 16 (3), 328-337, 2014 | 323 | 2014 |
| Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus Z Chen, L Mi, J Xu, J Yu, X Wang, J Jiang, J Xing, P Shang, A Qian, Y Li, ... The Journal of infectious diseases 191 (5), 755-760, 2005 | 313 | 2005 |
| Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study Z He, L Ren, J Yang, L Guo, L Feng, C Ma, X Wang, Z Leng, X Tong, ... The Lancet 397 (10279), 1075-1084, 2021 | 252 | 2021 |
| Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19 T Hou, W Zeng, M Yang, W Chen, L Ren, J Ai, J Wu, Y Liao, X Gou, Y Li, ... PLoS Pathogens 16 (8), e1008705, 2020 | 248 | 2020 |
| Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses B Wang, X Xi, X Lei, X Zhang, S Cui, J Wang, Q Jin, Z Zhao PLoS pathogens 9 (3), e1003231, 2013 | 243 | 2013 |
| Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3 X Lei, Z Sun, X Liu, Q Jin, B He, J Wang Journal of virology 85 (17), 8811-8818, 2011 | 222 | 2011 |
| The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses X Lei, X Liu, Y Ma, Z Sun, Y Yang, Q Jin, B He, J Wang Journal of virology 84 (16), 8051-8061, 2010 | 221 | 2010 |
CUI ShengInstitute of Pathogen Biology at Peking Union Medical CollegeVerified email at ipb.pumc.edu.cn
